EUVIMEDEUVIMED entdecken
Crossref

Differential effects of montelukast and zafirlukast on MDA‑MB‑231 triple‑negative breast cancer cells: Cell cycle regulation, apoptosis, autophagy, DNA damage and endoplasmic reticulum stress

Pornpun Vivithanaporn, Thanaporn Sriwantana, Kanokpan Krueaprasertkul, Nathawut Sibmooh, Suttinee Phuagkhaopong, Piyanuch Wonganan

Molecular Medicine Reports · 2024

DOI: 10.3892/mmr.2024.13265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2024. Verfasst von Pornpun Vivithanaporn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakarn 10540, Thailand. Hauptthemen laut MEDLINE: Sulfides, Cyclopropanes, Quinolines, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Montelukast and zafirlukast, cysteinyl leukotriene receptor antagonists (LTRAs), trigger apoptosis and inhibit cell proliferation of triple‑negative breast cancer MDA‑MB‑231 cells. By contrast, only zafirlukast induces G0/G1 cell cycle arrest. The present study compared the effects of these drugs on proteins regulating cell proliferation, apoptosis, autophagy, and endoplasmic reticulum (ER) and oxidative stress using reverse transcription‑quantitative PCR, western blotting and flow cytometry. The expression of proliferating markers, Ki‑67 and proliferating cell nuclear antigen, was decreased by both drugs. Zafirlukast, but not montelukast, decreased the expression of cyclin D1 and CDK4, disrupting progression from G1 to S phase. Zafirlukast also increased the expression of p27, a cell cycle inhibitor. Both drugs decreased the expression of anti‑apoptotic protein Bcl‑2 and ERK1/2 phosphorylation, and increased levels of the autophagy marker LC3‑II and DNA damage markers, including cleaved PARP‑1, phosphorylated (p)‑ATM and p‑histone H2AX. The number of caspase 3/7‑positive cells was greater in montelukast‑treated cells compared with zafirlukast‑treated cells. Montelukast induced higher levels of the ER stress marker CHOP compared with zafirlukast. Montelukast activated PERK, activating transcription factor 6 (ATF6) and inositol‑requiring enzyme type 1 (IRE1) pathways, while zafirlukast only stimulated ATF6 and IRE1 pathways. GSK2606414, a PERK inhibitor, decreased apoptosis mediated by montelukast, but did not affect zafirlukast‑induced cell death. The knockdown of CHOP by small interfering RNA reduced apoptosis triggered by montelukast and zafirlukast. In conclusion, the effects on cell cycle regulator proteins may contribute to cell cycle arrest caused by zafirlukast. The greater apoptotic effects of montelukast may be caused by the higher levels of activated caspase enzymes and the activation of three pathways of ER stress: PERK, ATF6, and IRE1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfidesCyclopropanesQuinolinesApoptosisAcetatesEndoplasmic Reticulum StressAutophagySulfonamidesIndolesDNA DamageHumansCell Line, TumorFemalePhenylcarbamatesTosyl CompoundsCell ProliferationeIF-2 KinaseEndoribonucleasesCell Cycle CheckpointsTranscription Factor CHOPCell CycleLeukotriene AntagonistsProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

CHOPLC3PARP‑1caspasecyclin Dendoplasmic reticulum stress

Substanzen

SulfidesCyclopropanesQuinolinesAcetatesSulfonamidesIndolesPhenylcarbamatesTosyl CompoundseIF-2 KinaseEndoribonucleases

Autor:innen und Institutionen

  • Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakarn 10540, Thailand.
  • Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
  • Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

Zitieren

APA

Vivithanaporn, P., Sriwantana, T., Krueaprasertkul, K., Sibmooh, N., Phuagkhaopong, S., & Wonganan, P. (2024). Differential effects of montelukast and zafirlukast on MDA‑MB‑231 triple‑negative breast cancer cells: Cell cycle regulation, apoptosis, autophagy, DNA damage and endoplasmic reticulum stress. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2024.13265

Vancouver

Vivithanaporn P, Sriwantana T, Krueaprasertkul K, Sibmooh N, Phuagkhaopong S, Wonganan P. Differential effects of montelukast and zafirlukast on MDA‑MB‑231 triple‑negative breast cancer cells: Cell cycle regulation, apoptosis, autophagy, DNA damage and endoplasmic reticulum stress. Molecular Medicine Reports. 2024. doi:10.3892/mmr.2024.13265

BibTeX
@article{Vivithanaporn2024,
  author = {Vivithanaporn, Pornpun and Sriwantana, Thanaporn and Krueaprasertkul, Kanokpan and Sibmooh, Nathawut and Phuagkhaopong, Suttinee and Wonganan, Piyanuch},
  title = {Differential effects of montelukast and zafirlukast on MDA‑MB‑231 triple‑negative breast cancer cells: Cell cycle regulation, apoptosis, autophagy, DNA damage and endoplasmic reticulum stress},
  journal = {Molecular Medicine Reports},
  year = {2024},
  doi = {10.3892/mmr.2024.13265}
}
Kostenlos starten →